The latest medical news on transthyretin amyloidosis
Online version
ATTR Expert
Tuesday February 04, 2025
ATTR Expert
Hello     ,
Below, you will find the latest scientific news regarding transthyretin amyloidosis, sourced from the most prestigious peer-reviewed journals.
News

Hereditary Transthyretin Amyloidosis in Patients Referred to a Genetic Testing Program
Journal of the American Heart Association 2024; 13(23): 033770 |  Kunal Bhatt MD et al.
In this analysis of ≥3 years of data from the hereditary amyloid transthyretin (hATTR) Compass Genetic Testing Program, approximately 7% of referred patients had a pathogenic transthyretin...
READ MORE +

Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region
Muscle & Nerve 2025; 71(2): 252-6 |  Ellie Jacoby et al.
Amyloidoses are a group of disorders, some of which are caused by genetic variants, characterized by abnormally folded proteins in tissues [1]. The most common genetic form, transthyretin amyloidosis (ATTRv),...
READ MORE +

The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study
The American Journal of Cardiology 2025; 237(In progress): 60-4 |  Chan, Nicholas et al.
Transthyretin cardiac amyloidosis (ATTR-CA) is disproportionately diagnosed in older men. However, studies suggest that the true prevalence of ATTR-CA in women may be greater than previously reported....
READ MORE +
Bibliographic data :  News  |  Archives  |  Highlight  |  My bibliography
Useful links:  Homepage  |  Bibliographic research
GNM Healthcare
Copyright 2025 © GNM Healthcare Consulting France SAS
With the institutional support of Alnylam Pharmaceuticals
Inform/Invite a colleague  | My account  | Delete my data
By requesting access to the "ATTR Expert" service, I agree that GNM Healthcare Consulting France SAS may use the data acquired during my access request to provide me with twice per month information related to its services in accordance with the Privacy Policy.
You have the right to access, rectify and delete your data, which you can exercise by sending your request to dpo@gnmhealthcare.com. You can exercise your right to object by requesting the deletion of your data at any time by clicking on the "Delete my data" link.